全球生技製藥產業研發聯盟成對夥伴關係與共同創新績效之研究：組織學習與社會交換觀點

Study on Dyadic Partnership and Joint Innovative Performance of R&D alliance in Global Biopharmaceutical Industry: Organizational Learning and Social Exchange Perspectives

徐之昇(Chih-Sheng Hsu)

指導教授 ： 吳青松 ； 吳學良

國立臺灣大學/管理學院/國際企業學研究所/博士(2013年)

https://doi.org/10.6342/NTU.2013.02357

摘要

研發聯盟於高科技產業之各類策略聯盟當中極為重要，且它已成為許多企業在國際商務上取得競爭優勢的重要途徑。但是，僅管研發聯盟為企業帶來了諸多好處，為數不少的研發聯盟卻仍然以失敗收場。究竟是什麼因素造成這些研發聯盟的高失敗率？過去許多學者提出研發聯盟中的夥伴關係是影響聯盟績之關鍵因素之一，並且認為未來需要更多的進一步實證研究來解答上述這個問題。本論文即回應這些學者的呼籲，利用經濟與社會之雙元觀點，檢視了夥伴間不對稱性(技術異質性、網絡資源不對稱性)與創新績效(創新速度、創新產量)之聯繫。研究結果指出夥伴間技術異質性與創新速度呈倒U型關係；對於1991-2000年間的聯盟與兩家生技公司共同合作的聯盟來說，網絡資源不對稱性與創新速度呈正向關係；網絡資源不對稱性與創新產量呈倒U型關係；此外，產品距離上市的時間會顯著地負向干擾上述關係。藉由解析各類夥伴關係對研發創新所造成的影響，以及了解產品研發階段因素之調節效果，本論文對於生技製藥產業研發聯盟之夥伴關係議題提出了許多理論上與實務上的貢獻。

關鍵字

研發聯盟 ； 夥伴關係 ； 創新 ； 組織學習觀點 ； 社會交換觀點

並列摘要

.Research and development (R&D) alliance is of great importance among various strategic alliances in high-tech industries, and it has become a vital strategy for many corporations to achieve competitive advantage in international business. Despite more and more companies benefited from R&D alliances, however, most of these alliances have failed. How come the high failure rate of R&D alliance happened? Prior researchers have proposed that the partner relationship plays a critical role for the performance of R&D alliance, and further empirical studies were consequently suggested for future research. In response to recent calls for inquiry into the issue regarding the effects of mutual relationships between partners, this dissertation aims to examine the links between partner asymmetries (technological heterogeneity and network resource asymmetry) and innovative performance (speed and quantity) from both economic and social dual perspectives and focusing on global biopharmaceutical industries. The results reveal an inverse U-shaped relationship between technology heterogeneity and innovation speed, a positive linear relationship between network resource asymmetry and innovation speed for 1991-2000 alliances and for BB partner type alliances, as well as an inverse U-shape relationship between network resource asymmetry and innovation quantity. Besides, there are significantly negative moderating effects of time to market on the above linear relations. Finally, this study makes important theoretical and practical contributions to partner selection literature on R&D alliances in the biopharmaceutical industry by highlighting not only the impacts of partner relationships on innovation, but also the moderating effects of product’s stage along the R&D process.

並列關鍵字

R&D alliance ； Partnership ； Innovation ； Organizational Learning Perspective ； Social Exchange Perspective

參考文獻

Ahuja, G. (2000), “The Duality of Collaboration: Inducements and Opportunities in the Formation of Interfirm Linkages”, Strategic Management Journal, 21(3): 317-343.

Ahuja, G.; Lampert, C.N. and Tandon, V. (2008), “Moving Beyond Schumpeter: Management Research on the Determinants of Technological Innovation”, Academy of Management Annals, 2(1): 1-98.

Allocca, M.A. and Kessler E.H. (2006), “Innovation Speed in Small and Medium-sized Enterprises”, Creativity and Innovation Management, 15(3): 279-295.

Anand, B. and Khanna N. (2000), “Do Firms Learn to Create Value: The Case of Alliances”, Strategic Management Journal, 21(3): 295-315.

Anderson, J.C. and Narus, J.A. (1990), “A Model of Distributor Firm and Manufacturer Firm Working Partnerships”, Journal of Marketing, 54(1): 42-58.